Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, 200011, PR China.
Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, 200011, PR China.
Redox Biol. 2021 Jul;43:101971. doi: 10.1016/j.redox.2021.101971. Epub 2021 Apr 17.
Oxidative stress-mediated retinal pigment epithelium (RPE) degeneration plays a vital role in retinal degeneration with irreversible visual impairment, most notably in age-related macular degeneration (AMD), but a key pathogenic factor and the targeted medical control remain controversial and unclear. In this work, by sophisticated high-throughput sequencing and biochemistry investigations, the major pathologic processes during RPE degeneration in the sodium iodate-induced oxidative stress model has been identified to be heme oxygenase-1 (HO-1)-regulated ferroptosis, which is controlled by the Nrf2-SLC7A11-HO-1 hierarchy, through which ferrous ion accumulation and lethal oxidative stress cause RPE death and subsequently photoreceptor degeneration. By direct knockdown of HO-1 or using HO-1 inhibitor ZnPP, the specific inhibition of HO-1 overexpression has been determined to significantly block RPE ferroptosis. In mice, treatment with ZnPP effectively rescued RPE degeneration and achieved superior therapeutic effects: substantial recovery of the retinal structure and visual function. These findings highlight that targeting HO-1-mediated RPE ferroptosis could serve as an effectively retinal-protective strategy for retinal degenerative diseases prevention, including AMD.
氧化应激介导的视网膜色素上皮 (RPE) 变性在具有不可逆视力损害的视网膜变性中起着至关重要的作用,尤其是在年龄相关性黄斑变性 (AMD) 中,但关键的致病因素和靶向医学治疗仍存在争议和不明确。在这项工作中,通过复杂的高通量测序和生物化学研究,已确定在碘酸钠诱导的氧化应激模型中 RPE 变性的主要病理过程是血红素加氧酶-1 (HO-1) 调控的铁死亡,这是由 Nrf2-SLC7A11-HO-1 级联调控的,其中亚铁离子积累和致命的氧化应激导致 RPE 死亡,随后感光细胞变性。通过直接敲低 HO-1 或使用 HO-1 抑制剂 ZnPP,确定了对 HO-1 过表达的特异性抑制可显著阻断 RPE 铁死亡。在小鼠中,ZnPP 的治疗有效挽救了 RPE 变性,并取得了优异的治疗效果:视网膜结构和视觉功能的显著恢复。这些发现强调了靶向 HO-1 介导的 RPE 铁死亡可能成为预防视网膜变性疾病的一种有效的视网膜保护策略,包括 AMD。